PH News

January 8, 2020January 8, 2020

Review Recommends International Consensus be Reached on What Constitutes PH in Newborns

News, PH News

An international consensus is lacking about what constitutes pulmonary hypertension (PH) in newborns, according to a review study, which recommends the use of standardized criteria to define the disease ... Read more

January 6, 2020January 6, 2020

Acceleron Pharma and Fulcrum Therapeutics Partner to Find Small Molecule Treatments

News, PAH News, PH News

Acceleron Pharma and Fulcrum Therapeutics are working together to discover small molecules that can be used to treat pulmonary diseases, including pulmonary hypertension (PH). Under this collaboration, Acceleron will ... Read more

January 3, 2020January 3, 2020

INOpulse Improves Physical Activity of ILD Patients at Risk of PH, Phase 2/3 Results Show

News, PH News

Bellerophon Therapeutics’ vasodilator INOpulse increased physical activity and improved quality of life in people with interstitial lung disease (PH-ILD) who are at risk of pulmonary hypertension, top-line results from a ... Read more

December 11, 2019December 11, 2019

PH Linked to Worse Outcomes in Patients Undergoing Mitral Valve Repair, Study Reports

News, PH News

Pulmonary hypertension (PH) is highly prevalent and linked to increased mortality and hospitalization among patients who underwent minimally invasive transcatheter mitral valve repair — the repair of the valve ... Read more

December 4, 2019December 4, 2019

PH Is Possible Complication of Bone Marrow Transplants in Children, Study Shows

News, PH News

Children who undergo bone marrow transplants could develop pulmonary hypertension (PH), which could lead to severe complications if not diagnosed and treated promptly, a retrospective study found. The study, ... Read more

November 27, 2019November 27, 2019

Liminal Biosciences’s PBI-4050 Reduces Pulmonary Hypertension, Preclinical Data Show

News, PH News

New preclinical data supports the positive effects of Liminal Biosciences’s lead candidate, PBI-4050, in reducing pulmonary hypertension and the abnormal enlargement of the heart’s right ventricle muscle. The company presented its ... Read more

November 22, 2019November 22, 2019

Access to Costly Therapies Top Concern of PH Patients in US, PHA’s Brad Wong Says

News, PH News

Like many rare disease charities, the Pulmonary Hypertension Association (PHA) was formed in 1991 by four women sitting around a kitchen table in Florida, hoping for a cure. Yet the ... Read more

November 18, 2019November 18, 2019

Bellerophon’s INOPulse Device Leads to Clinically Meaningful Improvements in PH-ILD, Early Data Shows

News, PH News

Use of Bellerophon Therapeutics’s INOpulse device led to clinically meaningful improvements in people with pulmonary hypertension associated with interstitial lung disease (PH-ILD), according to initial data from an ongoing ... Read more

November 13, 2019December 20, 2019

INOpulse Improves Physical Activity in PF Patients at Risk of PH, Early Trial Results Show

News, PH News

The vasodilator INOpulse increased physical activity and helped maintain higher levels of exercise in people at risk of pulmonary hypertension (PH) associated with pulmonary fibrosis (PH-PF), preliminary results from ... Read more

PH News

Review Recommends International Consensus be Reached on What Constitutes PH in Newborns

Acceleron Pharma and Fulcrum Therapeutics Partner to Find Small Molecule Treatments

Top 10 Pulmonary Hypertension Stories of 2019

INOpulse Improves Physical Activity of ILD Patients at Risk of PH, Phase 2/3 Results Show

PH Linked to Worse Outcomes in Patients Undergoing Mitral Valve Repair, Study Reports

PH Is Possible Complication of Bone Marrow Transplants in Children, Study Shows

Liminal Biosciences’s PBI-4050 Reduces Pulmonary Hypertension, Preclinical Data Show

Access to Costly Therapies Top Concern of PH Patients in US, PHA’s Brad Wong Says

Bellerophon’s INOPulse Device Leads to Clinically Meaningful Improvements in PH-ILD, Early Data Shows

INOpulse Improves Physical Activity in PF Patients at Risk of PH, Early Trial Results Show

Pin It on Pinterest